About Mobidiag
"Mobidiag Ltd. is a commercial stage, fast-growing Finnish-French biotechnology company. At Mobidiag, we develop and market innovative diagnostic solutions for Gastrointestinal Infections, Antimicrobial Resistance Management, Healthcare Associated Infections (HAIs), Respiratory Infections and Sepsis.
Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and instruments: Novodiag® (on-demand testing) and Amplidiag® (high-throughput, batch testing). These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and antibiotic resistances.
Mobidiag Ltd. is headquartered in Espoo, Finland, with subsidiaries in France, United Kingdom and Sweden.
- Founding: 2000
- Focus : Manufacturer
- Employees: 51-200
- Industry : Diagnostics
Product portfolio of Mobidiag
News about Mobidiag
Here you will find Mobidiag Ltd.
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
